Advertisement

Topics

Johnson Controls, Inc Company Profile

07:42 EST 19th December 2018 | BioPortfolio

Johnson Controls is a global leader in interior experience, building efficiency and power solutions. The company provides innovative automotive interiors that help make driving more comfortable, safe and enjoyable. For buildings, it offers products and services that optimize energy use and improve comfort and security. Johnson Controls also provides batteries for automobiles and hybrid electric vehicles, along with systems engineering and service expertise. Johnson Controls (NYSE: JCI), founded in 1885, is headquartered in Milwaukee, Wisconsin.~

Location

5757 N. Green Bay Ave
Milwaukee
Wisconsin
53209
United States of America

Contact

Phone: 414-524-1200
Email: webmaster@jci.com


News Articles [932 Associated News Articles listed on BioPortfolio]

Johnson & Johnson Posting Notable Loss But Well Off Lows

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have climbed well off their worst levels of the day but remain in negative territory in late-day trading on Friday. Johnson & Johnson is...

Johnson & Johnson verkauft Desinfektionssparte für 2,7 Milliarden Dollar: Johnson & Johnson steigt aus ...

Johnson & Johnson steigt aus dem Geschäft für Sterilisationsprodukte aus: Die Sparte übernimmt der Konzern Fortive für 2,7 Milliarden Dollar.Der Pharma- und Konsumgüterkonzern Johnson & Johnson (...

Johnson & Johnson Vision: FDA Approves IDESIGN Refractive Studio - Quick Facts

Johnson & Johnson Vision, a unit of Johnson & Johnson (JNJ), said that the U.S. Food and Drug Administration (FDA) has approved of the iDESIGN Refractive Studio, making it the only system to use topog...

Johnson & Johnson: The Fundamentals of Alliance Management

Johnson & Johnson were one of the first companies to realise the importance of an alliance management group closely following in rival Eli Lilly & Co.’s footsteps. Rob Wills, VP Alliance Management ...

Johnson & Johnson To Buy Remaining Stake In Japan's Ci:z In ¥230 Bln Deal

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced Tuesday its agreement to acquire the remaining stake of Japan's Ci:z Holdings Co., Ltd. which it does not already own.Johnson & Johnson ...

Johnson & Johnson: Pharmabereich beflügelt Quartalsergebnisse

Der amerikanische Konsumgüterhersteller Johnson & Johnson konnte im zurückliegenden Quartal die Markterwartungen deutlich schlagen. Analysten hatten im Vorfeld mit einem Gewinn je Aktie von 2,07 Do....

Johnson & Johnson will japanischen Hautpflege-Spezialisten kaufen

Von Megumi Fujikawa TOKIO (Dow Jones)--Der Pharma- und Konsumgüterhersteller Johnson & Johnson (J&J) will die japanische Ci:z Holdings komplett übernehmen. Der US-Konzern bietet laut Mitteilung in.....

Johnson & Johnson Innovation Opens JLABS @ NYC

NewsThe 30,000-square foot facility, located at the New York Genome Center in the heart of SoHo, is a collaboration between Johnson & Johnson Innovation, New York State, and the New York Genome Center...

PubMed Articles [631 Associated PubMed Articles listed on BioPortfolio]

An Analysis of the FDA MAUDE Database and the Search for Cobalt Toxicity in Class 3 Johnson & Johnson/DePuy Metal-on-Metal Hip Implants.

This study was designed to determine whether systemic cobalt toxicity as an adverse event could be documented using the Food and Drug Administration's (FDA) Manufacturer and User Facility Device Exper...

Stevens-Johnson Syndrome: A Challenging Diagnosis.

Stevens-Johnson syndrome is a rare, yet life-threatening, delayed-type hypersensitivity reaction characterized by mucocutaneous epidermal necrolysis. Toxic epidermal necrolysis is a severe manifestati...

Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are serious mucocutaneous reactions. In Spain, the epidemiology and resulting expenses of these diseases are not well established.

Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.

Methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening adverse drug reactions. Based on previous studies, HLA genotypes may play an important role...

Fluoxetine-induced Stevens-Johnson syndrome and liver injury.

Drug-induced liver injuries (DILI) are overall rare and often associated with use of medications. Medications are also the most common aetiology of Stevens-Johnson syndrome (SJS), but SJS is seldom se...

Clinical Trials [1416 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [293 Associated Companies listed on BioPortfolio]

Johnson Controls, Inc

Johnson Controls is a global leader in interior experience, building efficiency and power solutions. The company provides innovative automotive interiors that help make driving more comfortable, safe ...

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson Controls

Johnson Controls is a global diversified technology and industrial leader serving customers in over 150 countries. Our 130,000 employees create quality products, services and solutions to optimize ene...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

More Information about "Johnson Controls, Inc" on BioPortfolio

We have published hundreds of Johnson Controls, Inc news stories on BioPortfolio along with dozens of Johnson Controls, Inc Clinical Trials and PubMed Articles about Johnson Controls, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson Controls, Inc Companies in our database. You can also find out about relevant Johnson Controls, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record